Results 161 to 170 of about 2,296 (190)
Some of the next articles are maybe not open access.
Biochemical and Biophysical Research Communications, 2006
Tumor protein D52-like proteins (TPD52) are small coiled-coil motif bearing proteins that were first identified in breast cancer. TPD52 and related proteins have been implicated in cell proliferation, apoptosis, and vesicle trafficking. To date, three human TPD52 members had been identified, named hD52 (TPD52), hD53 (TPD52L1), and hD54 (TPD52L2).
Qinhong, Cao +7 more
openaire +2 more sources
Tumor protein D52-like proteins (TPD52) are small coiled-coil motif bearing proteins that were first identified in breast cancer. TPD52 and related proteins have been implicated in cell proliferation, apoptosis, and vesicle trafficking. To date, three human TPD52 members had been identified, named hD52 (TPD52), hD53 (TPD52L1), and hD54 (TPD52L2).
Qinhong, Cao +7 more
openaire +2 more sources
Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening [PDF]
Tumor protein D52 (TPD52) is overexpressed in different cancers, but its molecular functions are poorly defined. A large, low-stringency yeast two-hybrid screen using full-length TPD52 bait identified known partners (TPD52, TPD52L1, TPD52L2, MAL2) and four other preys that reproducibly bound TPD52 and TPD52L1 baits (PLP2, RAB5C, GOLGA5, YIF1A).
Brian J Smith +2 more
exaly +3 more sources
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
International Journal of Cancer, 2005AbstractRecurrent chromosome 8q gain in ovarian carcinoma is likely to reflect the existence of multiple target loci, as the separate gain of chromosome bands 8q21 and 8q24 has been reported in independent studies. Since tumor protein D52 (TPD52) has been identified as a chromosome 8q21 amplification target in breast and prostate carcinoma, we compared
Jennifer A, Byrne +12 more
openaire +2 more sources
TPD52 represents a survival factor inERBB2‐amplified breast cancer cells
Molecular Carcinogenesis, 2013AbstractTPD52 and ERBB2 co‐expression has been persistently reported in human breast cancer and animal models of this disease, but the significance of this is unknown. We identified significant positive associations between relativeTPD52andERBB2transcript levels in human diagnostic breast cancer samples, and maximalTPD52expression in the hormone ...
Nuruliza, Roslan +5 more
openaire +2 more sources
Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis
Journal of Cellular Biochemistry, 2018AbstractGenerating accurate prognoses is extremely important for treating patients with cancer. Prognostic prediction based on messenger RNA (mRNA) expression has shown superior clinical value to other markers for some cancers but is not currently used for acute myeloid leukemia (AML).
Mihyang Ha +5 more
openaire +2 more sources
Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells
The tumour protein D52 isoform 1 (PC-1), a member of the tumour protein D52 (TPD52) protein family, is androgen-regulated and prostate-specific expressed. Previous studies confirmed that PC-1 contributes to malignant progression in prostate cancer with an important role in castration-resistant stage.
Moritz, Tom +5 more
exaly +4 more sources
Heightened TPD52 linked to metabolic dysfunction and associated abnormalities in zebrafish
Archives of Biochemistry and BiophysicsThe tumor protein D52 (TPD52) gene encodes a proto-oncogene protein associated with various medical conditions, including breast and prostate cancers. It plays a role in multiple biological pathways such as cell growth, differentiation, and apoptosis. The function of TPD52 in lipid droplet biosynthesis has been investigated in vitro.
Hsin-Hung Lai +4 more
openaire +2 more sources
Biochemical and Biophysical Research Communications, 2015
The tumor protein D52 (TPD52) is an oncogene overexpressed in prostate cancer (PC) due to gene amplification. Although the oncogenic effect of TPD52 is well recognized, how its expression is regulated is still not clear. This study tried to explore the regulative role of miR-218, a tumor suppressing miRNA on TPD52 expression and prostate cancer cell ...
Guangye, Han +2 more
exaly +3 more sources
The tumor protein D52 (TPD52) is an oncogene overexpressed in prostate cancer (PC) due to gene amplification. Although the oncogenic effect of TPD52 is well recognized, how its expression is regulated is still not clear. This study tried to explore the regulative role of miR-218, a tumor suppressing miRNA on TPD52 expression and prostate cancer cell ...
Guangye, Han +2 more
exaly +3 more sources
Functional Roles of Tumor Protein D52 (TPD52) in Breast Cancer
Current Cancer Therapy Reviews: Breast cancer is an aggressive disease with a significant morbidity and death rate among women worldwide. Despite the progress of diagnostic and therapy options for breast cancer in recent years, the prognosis and survival rates of breast cancer patients remain unsatisfactory.
Mojtaba Zehtabi +6 more
openaire +1 more source
TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumours
Molecular and Cellular Endocrinology, 2009Several genomic regions are recurrently over- or underrepresented in testicular germ cell tumours (TGCTs), but only a fraction of their genes change their expression accordingly. Two publications to date have studied DNA copy numbers and associated gene expression changes on a genome-wide level to identify key players in TGCT tumorigenesis.
Sharmini, Alagaratnam +4 more
openaire +2 more sources

